SCHEMBL26441880

SCHEMBL26441880

Cc1ccc(C(=O)c2cc(O)c(C)c(O)c2)c(O)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.58
▸ KDM4E B2RXH2 5/20 0.43
▸ MAPT P10636 5/20 0.43
▸ HSD17B10 Q99714 4/20 0.43
▸ ALOX15 P16050 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 3/20 0.43
▸ RECQL P46063 3/20 0.43
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ MAPK1 P28482 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ BCL2 P10415 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26441471 0.91 HDAC1 (0.70) HDAC1KDM4EMAPTHSD17B10ALOX15
SCHEMBL19763340 0.87 HDAC1 (0.76) HDAC1KDM4EMAPTHSD17B10ALOX15
SCHEMBL26441478 0.83 HDAC1 (0.51) HDAC1KDM4EMAPTHSD17B10ALOX15
SCHEMBL17357499 0.80 HDAC1 (0.59) HDAC1KDM4EMAPTHSD17B10ALOX15
SCHEMBL30577999 0.78 ALDH1A1 (0.56) HDAC1KDM4EMAPTHSD17B10ALOX15
SCHEMBL28687922 0.78 KDM4E (0.62) KDM4EMAPTHSD17B10ALOX15ALDH1A1
SCHEMBL26441474 0.77 MAPT (0.46) HDAC1KDM4EMAPTHSD17B10ALOX15
SCHEMBL26441706 0.76 HDAC1 (0.70) HDAC1KDM4EMAPTHSD17B10ALOX15
SCHEMBL26441808 0.76 HDAC1 (0.54) HDAC1KDM4EMAPTHSD17B10ALOX15
SCHEMBL26441450 0.76 TUBB4A (0.54) KDM4EMAPTHSD17B10ALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11639325-B2 Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11639325-B2 Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders HDAC1, HDAC10, HDAC6 HDAC1 1/4885KDM4E 418/4885MAPT 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback